Antiretroviral News and Research

RSS
IRIN/PlusNews examines issues surrounding HIV-positive teenagers in Burkina Faso

IRIN/PlusNews examines issues surrounding HIV-positive teenagers in Burkina Faso

Boehringer, Gilead freeze antiretroviral prices for some U.S. agencies

Boehringer, Gilead freeze antiretroviral prices for some U.S. agencies

Uganda MP calls for increased antiretroviral access at rural health clinics

Uganda MP calls for increased antiretroviral access at rural health clinics

Indian Government to establish small antiretroviral clinics to provide treatment to more people from rural areas

Indian Government to establish small antiretroviral clinics to provide treatment to more people from rural areas

Report on HIV/AIDS drug access shows 'encouraging, painfully slow progress,' editorial says

Report on HIV/AIDS drug access shows 'encouraging, painfully slow progress,' editorial says

Longer treatment with antiretroviral Nevirapine reduces risk of HIV among infants

Longer treatment with antiretroviral Nevirapine reduces risk of HIV among infants

Jamaican Health Ministry secures 40% of funding for $200 million plan to fight HIV/AIDS

Jamaican Health Ministry secures 40% of funding for $200 million plan to fight HIV/AIDS

Speakers at second HIV/AIDS implementers' meeting in Uganda call for increased HIV prevention efforts

Speakers at second HIV/AIDS implementers' meeting in Uganda call for increased HIV prevention efforts

9.7 million at risk of death from AIDS today, AHF calls for ARV treatment scale-up

9.7 million at risk of death from AIDS today, AHF calls for ARV treatment scale-up

UK to provide about $12 billion to improve health services in developing countries, fight HIV/AIDS, official says

UK to provide about $12 billion to improve health services in developing countries, fight HIV/AIDS, official says

One million people gained access to antiretrovirals in 2007

One million people gained access to antiretrovirals in 2007

Boehringer Ingelheim, Gilead to freeze AIDS drug price

Boehringer Ingelheim, Gilead to freeze AIDS drug price

3 million now receiving anti-retroviral therapy HIV drugs

3 million now receiving anti-retroviral therapy HIV drugs

Thailand's removal of official who supported compulsory licensing 'important' step to 'protecting patients' health,' editorial says

Thailand's removal of official who supported compulsory licensing 'important' step to 'protecting patients' health,' editorial says

Guyanese Health Minister Ramsammy discusses HIV/AIDS, health worker shortages at World Health Assembly

Guyanese Health Minister Ramsammy discusses HIV/AIDS, health worker shortages at World Health Assembly

HIV patients suffer more from osteoporosis

HIV patients suffer more from osteoporosis

St. Louis Post-Dispatch examines small pharmacies' efforts to provide specialized services to people living with HIV/AIDS

St. Louis Post-Dispatch examines small pharmacies' efforts to provide specialized services to people living with HIV/AIDS

Uganda AIDS Commission drafts plan to streamline HIV/AIDS messages

Uganda AIDS Commission drafts plan to streamline HIV/AIDS messages

Study finds increased risk of some cancers among HIV-positive people in U.S.

Study finds increased risk of some cancers among HIV-positive people in U.S.

Ugandan group launches no-cost HIV testing campaign aimed at children, urges parents to test children

Ugandan group launches no-cost HIV testing campaign aimed at children, urges parents to test children

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.